North America Breast Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers North America Breast Cancer Diagnosis Test and the market is Segmented by Test (Genomic Tests and Imaging Tests) and Geography (United States, Canada, and Mexico). The market provides the value (in USD million) for the above-mentioned segments.

North America Breast Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Breast Cancer Screening Tests Market Size

View Global Report
North America Breast Cancer Screening Tests Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 8.44 %
Market Concentration Low

Major Players

North America Breast Cancer Screening Tests Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Breast Cancer Screening Tests Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Breast Cancer Screening Tests Market Analysis

The North America Breast Cancer Screening Tests Market is expected to register a CAGR of 8.44% during the forecast period.

  • The COVID-19 pandemic significantly impacted the breast cancer screening test market. Diagnostic procedures were postponed at the pandemic's beginning as the hospitals and surgeons were advised to postpone or cancel elective courses. For instance, according to a study published by the National Library of Medicine (NLM) in June 2022, mammography rates were more impacted during the pandemic than the number of breast cancer operations. By 2030, the study projects 950 cumulative excess breast cancer deaths related to reduced screening and 1,314 associated with delayed diagnosis of symptomatic cases.
  • The study also stated that the initial pandemic-related disruptions in breast cancer care would have a negligible long-term effect on breast cancer mortality. This has impacted the growth of the breast cancer screening test market during the pandemic. However, the market is gradually stabilizing as COVID-19 cases are declining, resulting in the return of the normal demand levels for diagnostic procedures.
  • The primary factors driving the market growth include the rising incidence of breast cancer and technological advancements in breast cancer screening. For instance, according to the Canadian Cancer Society update, in May 2022, 28,600 Canadian women were diagnosed with breast cancer, representing 25% of all new cancer cases in women in 2022.
  • Furthermore, according to a Center for Disease Prevention (CDC) update in September 2022, the risk of breast cancer increases with age. Most breast cancers are diagnosed after age 50. Thus, with an increase in breast cancer cases due to the rise in the geriatric population, the demand for breast cancer screening tests increases, thereby driving the market's growth.
  • Furthermore, technological advances in imaging are creating new opportunities for improvements in screening and early detection. For instance, according to National Cancer Institute (NCI), in January 2022, NCI funded a large-scale randomized breast screening trial, the tomosynthesis mammographic imaging screening trial (TMIST), to compare the number of advanced cancers detected in women screened for five years with 3-D mammography with the number seen in women screened with 2-D mammography. Such initiatives are expected to increase the demand for breast cancer screening tests, eventually driving the market's growth.
  • Additionally, the rising initiative of critical players in developing innovative strategies is further expected to drive market growth over the forecast period. For instance, in October 2022, the American College of Radiology (ACR) launched the contrast-enhanced mammography imaging screening Trial (CMIST) in collaboration with the Breast Cancer Research Foundation (BCRF) and GE Healthcare. The trial determined whether contrast-enhanced mammography improves breast cancer detection and reduces false-positive exams in women with dense breasts. Such initiatives will lead to increased adoption of breast cancer screening, driving market growth.
  • Therefore, the factors mentioned above, such as the rising incidence of breast cancer and technological advancements in breast cancer screening, are attributed collectively to the studied market growth over the forecast period. However, controversies related to mammography and side effects of radiation during screening tests and errors in screening are the major factors restraining the market's growth.

North America Breast Cancer Screening Tests Industry Overview

The North American breast cancer screening tests market is fragmented in nature due to the presence of several companies operating regionally. The competitive landscape includes an analysis of companies, including Agendia BV, Fujifilm Holdings Corporation, Hologic Inc., Metabolomic Technologies Inc., Myriad Genetics, QIAGEN NV, Quest Diagnostics Incorporated, and Siemens Healthineers, among others.

North America Breast Cancer Screening Tests Market Leaders

  1. Allengers Medical Systems Limited

  2. Myriad Genetics

  3. Siemens Healthineers

  4. Hologic Inc.

  5. GENERAL ELECTRIC COMPANY

  6. *Disclaimer: Major Players sorted in no particular order
North America Breast Cancer Screening Tests Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

North America Breast Cancer Screening Tests Market News

  • February 2023: To transform breast care with automated imaging and artificial intelligence (AI), Abdul Latif Jameel Health signed a distribution agreement with iSono Health, a medical technology company in San Francisco, US.
  • October 2022: The University of Texas MD Anderson Cancer Center and the World Health Organization (WHO) signed a formal agreement to establish a new international collaboration to reduce the global burden of women's cancers. The agreement builds on years of collaboration between the two institutions to further promote their shared efforts in advancing global cancer initiatives in women's cancers, including breast and cervical cancers.

North America Breast Cancer Screening Tests Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Breast Cancer
    • 4.2.2 Technological Advancements in Breast Cancer Screening
  • 4.3 Market Restraints
    • 4.3.1 Controversies Related to Mammography
    • 4.3.2 Side Effects of Radiation during Screening Tests and Errors in Screening
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Test
    • 5.1.1 Genomic Tests
    • 5.1.2 Imaging Test
    • 5.1.2.1 Mammogram
    • 5.1.2.2 Ultrasound
    • 5.1.2.3 MRI
    • 5.1.2.4 Tomography
    • 5.1.2.5 Other Imaging Tests
  • 5.2 Geography
    • 5.2.1 United States
    • 5.2.2 Canada
    • 5.2.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allengers Medical Systems Limited
    • 6.1.2 Fujifilm Holdings Corporation
    • 6.1.3 Hologic Inc.
    • 6.1.4 GE Healthcare
    • 6.1.5 Myriad Genetics
    • 6.1.6 QIAGEN NV
    • 6.1.7 Quest Diagnostics Incorporated
    • 6.1.8 Siemens Healthineers
    • 6.1.9 Analogic Corporation
    • 6.1.10 Aurora Healthcare US Corp
    • 6.1.11 Agendia Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Breast Cancer Screening Tests Industry Segmentation

As per the scope of the report, breast cancer screening is carried out to detect cancer in its early stages and ensure timely treatment for the patients.

The North American breast cancer screening tests market is segmented by test (genomic tests and imaging tests (mammogram, ultrasound, MRI, tomography, and other imaging tests)) and geography (United States, Canada, and Mexico).

The report offers the value (in USD) for the above segments.

By Test Genomic Tests
Imaging Test Mammogram
Ultrasound
MRI
Tomography
Other Imaging Tests
Geography United States
Canada
Mexico
Need A Different Region or Segment?
Customize Now

North America Breast Cancer Screening Tests Market Research FAQs

What is the current North America Breast Cancer Screening Tests Market size?

The North America Breast Cancer Screening Tests Market is projected to register a CAGR of 8.44% during the forecast period (2025-2030)

Who are the key players in North America Breast Cancer Screening Tests Market?

Allengers Medical Systems Limited, Myriad Genetics, Siemens Healthineers, Hologic Inc. and GENERAL ELECTRIC COMPANY are the major companies operating in the North America Breast Cancer Screening Tests Market.

What years does this North America Breast Cancer Screening Tests Market cover?

The report covers the North America Breast Cancer Screening Tests Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Breast Cancer Screening Tests Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Breast Cancer Screening Industry Report

Statistics for the 2025 North America Breast Cancer Screening Tests market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Breast Cancer Screening Tests analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.